Clinical trial
Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
NCT02861287 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Economic Evaluation of the Use of Plerixafor for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
- Lead sponsor
- Institut Paoli-Calmettes
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- Not reported
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.